HOME > 業績集 > Antitumor Activity of MEK and PI3K Inhibitors Against Malignant Pleural Mesothelioma Cells in Vitro and in Vivo. Antitumor Activity of MEK and PI3K Inhibitors Against Malignant Pleural Mesothelioma Cells in Vitro and in Vivo. 2012年10月01日 ← Effects of a Benidipine-Based Combination Therapy on the Risk of Stroke According to Stroke Subtype: the COPE Trial. Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPARγ Activation. →